SIMPONI ARIA® is indicated for the treatment of adults with joint and ankle problems, like rheumatoid arthritis (RA) , Active psoriatic arthritis (PsA) and Active ankylosing spondylitis (AS). SIMPONI ARIA® was in the middle of FDA approval. And client wanted to share this update for HCP and patient.
And Remicade is marketed by Janssen Biotech, Inc. And Remicade was approved by the U.S. FDA for the treatment of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.
Janssen presented FinelyTuned.com to learn more about real patients’ stories about Remicade.